Regencell Bioscience Holdings Limited (RGC) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Regencell Bioscience Holdings Limited
Address
First Commercial Building
Causeway Bay, KY1-1107
Hong Kong
Phone
852 2155 0823
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
12
First IPO Date
July 16, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Yat-Gai Au | Founder, Chairman & Chief Executive Officer | 0 | 1973 |
| Wai Hong Chung | Chief Operating Officer, Chief Strategy Officer & Director | 245,642 | 1978 |
| Yat-Pui Au | Chief Business Officer | 0 | 1975 |
| Antonia Assang | Senior Vice President of Project Management | 0 | N/A |
| Michelle Chan | Financial Controller, Chief Financial Officer & Principal Financial Officer | 0 | N/A |
AD
Description
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
AD
